Miragen Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $208k | 9.1k | 22.75 |
| 2023-09-30 | $1.2M | 80k | 15.34 |
| 2023-06-30 | $3.5M | 148k | 23.79 |
| 2023-03-31 | $3.5M | 136k | 25.44 |
| 2022-12-31 | $3.8M | 132k | 29.21 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management